BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saravanan KM, Kannan M, Meera P, Bharathkumar N, Anand T. E3 ligases: a potential multi-drug target for different types of cancers and neurological disorders. Future Medicinal Chemistry. [DOI: 10.4155/fmc-2021-0157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Zhan Y, Li M, Wang L, Zheng A, Liu C, Wang H, Wang T. Cell-Permeable PROTAC Degraders against KEAP1 Efficiently Suppress Hepatic Stellate Cell Activation through the Antioxidant and Anti-Inflammatory Pathway. ACS Pharmacol Transl Sci 2023;6:76-87. [PMID: 36654751 DOI: 10.1021/acsptsci.2c00165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gao Y, Xiao X, Luo J, Wang J, Peng Q, Zhao J, Jiang N, Zhao Y. E3 Ubiquitin Ligase FBXO3 Drives Neuroinflammation to Aggravate Cerebral Ischemia/Reperfusion Injury. IJMS 2022;23:13648. [DOI: 10.3390/ijms232113648] [Reference Citation Analysis]